Designed for trade association, exhibitors, academic institutions and speakers, List and promote your online events
Largest database of verified shows since 2015, Detailed profiles of verified trade shows, conferences and consumer shows. Create your event and attract attendees and exhibitiors, Listing tools for verification, institution and corporation.
Connect with verified event organizers, Listing and RFP tools for verified venue operators.Size events by verified attendee and exhibitor count database
Research verified b2b events by industry and profession, Review virtual exhibitor showcase. Create Profile. Connect with verified event organizers and exhibitors.
Search 900k verified exhibitor database organizedby 2,000+ events since 2018.
The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 12th year, is a unique and exciting multidisciplinary program, to be held this year at the Hilton Hotel in Universal City, California. The Congress is the premiere global meeting dedicated to obesity, diabetes, metabolism, and energy balance, linking research to clinical practice, and highlighting our theme - exploring new frontiers in metabolism - tomorrow's clinical science today.
Since its inception, the Congress has become a home to clinical & basic scientists, researchers, and practicing clinicians. The distinguished global faculty, employing the Congress’ unique bench-to-bedside approach, has developed a state-of-the-art program, promoting a new understanding of metabolic diseases; facilitate the development of future therapeutic modalities; and implement the management of obesity and diabetes with contemporary medications.
Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance and diabetes & cardiovascular disease (CVD), the Congress’ focus has been augmented by the role of obesity, fat cell, and inflammation, in furthering cardiometabolic disease. The WCIRDC has become a distinguished platform where the interaction of multiple metabolic systems, like circadian rhythm, sleep disturbances, the neuroendocrine system, the gut, and related hormones, and their relationship to the brain, are evaluated in both the scientific and clinical environments. Ultimately the Congress is set on developing an innovative and comprehensive plan for managing CV risk factors and diseases.
This year will focus on the scientific basis for congestive heart failure (CHF), peripheral vascular disease (PVD), and thrombosis; and new therapeutic modalities to allow clinical management of these conditions.
This course is designed for endocrinologists, cardiologists, gastroenterologists, oncologists, family physicians, internists, diabetologists, OBGYNs, pediatricians, dieticians, nurses, registered nurses, and any health care professional who is interested in insulin resistance and the interaction of multiple metabolic mechanisms, and the effect on health and society, as well as in potential treatment and prevention.
We offer Exhibit space to expand your company’s appreciation, and to expose your products and services to the nearly 500 health care professionals who attend the annual meeting.
The WCIRDC is an excellent opportunity to meet with globally-recognized medical leaders, clinicians and scientists who present and share their knowledge. The WCIRDC is designed to evaluate both clinical and basic science aspects of insulin resistance, obesity, diabetes, and CVD. The WCIRDC achieves a great balance between clinical practice and research, by utilizing a state of the art approach: “Exploring new frontiers in metabolism - Tomorrow’s Clinical Science Today!”
The WCIRDC will dedicate an area, separate from the educational program, where your company will be able to exhibit products, equipment and services.
Source : Event Website
|17th Annual World Congress On Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)||Los Angeles||California||-||-||Dec 04, 2019|
|16th Annual World Congress On Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)||Los Angeles||California||-||
|Nov 29, 2018|
|15th Annual World Congress On Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)||Washington||District of Columbia||-||
|Nov 30, 2017|
|14th WCIRDC - World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease||Los Angeles||California||
|-||Dec 01, 2016|
|13th Annual World Congress On Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)||Universal City||California||-||-||Nov 19, 2015|
|12th Annual World Congress On Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)||Universal City||California||-||-||Nov 20, 2014|
|ASE Echo Hawaii 2021 - American Society of Echocardiography||Waimea||Hawaii||
|-||Jan 18, 2021|
|2021 Mayo Clinic Hawaii Echo with Multimodality Imaging - Cardiovascular Medicine CME||Wailea||Hawaii||-||-||Jan 24, 2021|
|Mayo Clinic Arrhythmias and the Heart: A Cardiovascular Update 2020||Waimea||Hawaii||
|-||Feb 01, 2021|
|Tremblant Interventional Cardiology Meeting - TIC 2021||Montreal||Quebec||-||-||Feb 03, 2021|
|Valve Disease, Structural Interventions, and Diastology Summit 2021||-||-||Feb 05, 2021|